Article Details

Eisai's Commitment to Scientific Evidence and Patient Safety - PR Newswire

Retrieved on: 2023-01-06 19:38:58

Tags for this article:

Click the tags to see associated articles and topics

Eisai's Commitment to Scientific Evidence and Patient Safety - PR Newswire. View article details on hiswai:

Excerpt

On November 29, 2022, the confirmatory Phase III CLARITY AD clinical trial results for LEQEMBI were published in The New England Journal of Medicine6 ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up